Panacea Biotec Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Panacea Biotec Ltd with three other
pharmaceutical manufacturers in Asia:
sales of 2.47 billion Japanese Yen [US$21.60 million]
of which 64%
was Health Inspection Equipment),
Ina Research Incorporation
(2.12 billion Japanese Yen [US$18.48 million]
of which 80%
was Non-clinical business), and
Pharma Foods International Co.Ltd
based in Japan
(3.46 billion Japanese Yen [US$30.21 million]
of which 60%
was Functional product(Online business)).
Panacea Biotec Ltd reported sales of 6.53 billion Indian Rupees (US$95.81 million)
March of 2016.
decrease of 5.0%
versus 2015, when the company's sales were 6.87 billion Indian Rupees.
Contributing to the drop in overall sales was the 45.1% decline
in Research and Development, from 238.20 million Indian Rupees to 130.80 million Indian Rupees.
There were also decreases in sales in
Formulation (down 0.1% to 3.87 billion Indian Rupees)
Vaccine (down 8.4% to 2.53 billion Indian Rupees)